title: The role of hyperthermic perfusion in the treatment of tumors of the extremities.
authors.affiliation: Department of Surgery, Regina Elena National Cancer Institute, Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Di Filippo
authors.forename: S
authors.initials: S
authors.lastname: Carlini
authors.forename: F
authors.initials: F
authors.lastname: Cavaliere
authors.forename: D
authors.initials: D
authors.lastname: Giannarelli
authors.forename: L
authors.initials: L
authors.lastname: Cavallero
authors.forename: F
authors.initials: F
authors.lastname: Moscarelli
authors.forename: L
authors.initials: L
authors.lastname: Aloe
authors.forename: R
authors.initials: R
authors.lastname: Cavaliere
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D010478:Chemotherapy, Cancer, Regional Perfusion; D002945:Cisplatin / Q000627:therapeutic use; D003609:Dactinomycin / Q000008:administration & dosage; D005112:Extracorporeal Circulation; D005121:Extremities; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods; D008545:Melanoma / Q000188:drug therapy / Q000628:therapy*; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local; D012516:Osteosarcoma / Q000188:drug therapy / Q000628:therapy; D012509:Sarcoma / Q000188:drug therapy / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy / Q000628:therapy; D015996:Survival Rate
chemical_list: D003609:Dactinomycin; D002945:Cisplatin; D008558:Melphalan